InvestorsHub Logo
Followers 1
Posts 59
Boards Moderated 0
Alias Born 01/17/2017

Re: biotech_researcher post# 7678

Monday, 12/03/2018 9:03:31 PM

Monday, December 03, 2018 9:03:31 PM

Post# of 17446
I agree, Biotech. $30M is for DES. I just think Dr Glickman is keeping his options open with an extra $30M in order to get the best deal in partnering for DES clinical development.

You can always get a better deal when you don’t really need one.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News